Literature DB >> 22424182

β-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides.

Tae-Kil Eom1, Bomi Ryu, Jung-Kwon Lee, Hee-Guk Byun, Sun-Joo Park, Se-Kwon Kim.   

Abstract

Eight kinds of phenolic acid conjugated chitooligosaccharides (COSs) were synthesized using hydroxyl benzoic acid and hydroxyl cinnamic acid. These phenolic acid conjugated-COSs with different substitution groups, including p-hydroxyl, 3,4-dihydroxyl, 3-methoxyl-4-hydroxyl and 3,5-dimethoxyl-4-hydroxy groups, were evaluated for their inhibitory activities against β-site amyloid precursor protein (APP)-cleaving enzyme (BACE) and inhibited BACE with a ratio of 50.8%, 74.8%, 62.1%, 64.8% and 42.6%, respectively at the concentration of 1,000 μg/mL. BACE is a critical component to reduce the levels of Aβ amyloid peptide in Alzheimer's disease (AD) which is based on the amyloid cascade theory in the brain, as this protease initiates the first step in Aβ production. Among them, Caffeic acid conjugated-COS (CFA-COS) was further analysed to determine mode of inhibition of BACE and it showed non-competitive inhibition. Hence in this study, we suggest that CFA-COS derivatives have potential to be used as novel BACE inhibitors to reduce the risk of AD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22424182     DOI: 10.3109/14756366.2011.629197

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  7 in total

1.  Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model.

Authors:  Ji Hyun Kim; Qian Wang; Ji Myung Choi; Sanghyun Lee; Eun Ju Cho
Journal:  Nutr Res Pract       Date:  2015-05-22       Impact factor: 1.926

2.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 3.  A Review of the Preparation, Analysis and Biological Functions of Chitooligosaccharide.

Authors:  Shuang Liang; Yaxuan Sun; Xueling Dai
Journal:  Int J Mol Sci       Date:  2018-07-27       Impact factor: 5.923

4.  Cloning and Characterization of a New Chitosanase From a Deep-Sea Bacterium Serratia sp. QD07.

Authors:  Qiuling Zheng; Xiangjun Meng; Mingyang Cheng; Yanfeng Li; Yuanpeng Liu; Xuehong Chen
Journal:  Front Microbiol       Date:  2021-02-24       Impact factor: 5.640

5.  Preparation and characterization of squid pen chitooligosaccharide-epigallocatechin gallate conjugates and their antioxidant and antimicrobial activities.

Authors:  Avtar Singh; Soottawat Benjakul; Nurul Huda; Changan Xu; Peng Wu
Journal:  RSC Adv       Date:  2020-09-08       Impact factor: 4.036

6.  New Nanomaterials with Intrinsic Antioxidant Activity by Surface Functionalization of Niosomes with Natural Phenolic Acids.

Authors:  Elisabetta Mazzotta; Carla Orlando; Rita Muzzalupo
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

Review 7.  Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease.

Authors:  Qian-Qian Ouyang; Shannon Zhao; Si-Dong Li; Cai Song
Journal:  Mar Drugs       Date:  2017-11-07       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.